Light-adaptation attenuates the effects of phosphodiesterase blackade by Zaprinast in the isolated rat retina.
Neurosci Lett
; 357(3): 195-8, 2004 Mar 11.
Article
em En
| MEDLINE
| ID: mdl-15003283
The effect of the type V/VI-selective phosphodiesterase inhibitor, Zaprinast, (200 microM) on the light-evoked extracellular field potential (EFP) in the isolated rat retina was tested under dark- and light-adapted conditions at two different temperatures. Peak enhancement EFP in dark- (344 +/- 70%; mean +/- SEM) and light-adapted (182 +/- 31%) retina at 37 degrees C was reached within 3 min of treatment with Zaprinast (200 microM) followed by a slower decrease to a level of 85 +/- 14 and 26 +/- 7% in dark- and light-adapted retina, respectively. The effect of Zaprinast (20 microM) on the pharmacologically-isolated photoreceptor component of the EFP was lost with increasing levels of background light. This may suggest that there is a slow time scale (minutes) shift in the steady state level of cGMP during light-adaptation.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Inibidores de Fosfodiesterase
/
Purinonas
/
Retina
/
Adaptação Ocular
Limite:
Animals
Idioma:
En
Ano de publicação:
2004
Tipo de documento:
Article